Skip to content
10-K

Annual Report

BioPlus Acquisition Corp.

0001193125-23-087738

← back to feed
Filed
Mar 31, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2022 · Dec 31, 2022 −$691.47K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$773.94K
Stockholders Equity FY 2022 · Dec 31, 2022 −$14.78M
Stockholders Equity FY 2022 · Dec 31, 2021 −$13.6M
Stockholders Equity FY 2022 · Feb 10, 2021 $0
Current Liabilities FY 2022 · Dec 31, 2022 $526.88K
Current Liabilities FY 2022 · Dec 31, 2021 $179.14K
Total Liabilities FY 2022 · Dec 31, 2022 $15.33M
Total Liabilities FY 2022 · Dec 31, 2021 $14.98M
Current Assets FY 2022 · Dec 31, 2022 $548.76K
Current Assets FY 2022 · Dec 31, 2021 $1M
Total Assets FY 2022 · Dec 31, 2022 $238.32M
Total Assets FY 2022 · Dec 31, 2021 $235.98M
Net Income FY 2022 · Dec 31, 2022 $2M
Net Income FY 2022 · Dec 31, 2021 −$140.2K
Operating Income FY 2022 · Dec 31, 2022 −$1.17M
Operating Income FY 2022 · Dec 31, 2021 −$148.9K